AS

Ariba Siddique

Active Director Director DIN 09488466
DIN 09488466 First appointment Feb 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Ariba Siddique

Data last updated:

Ariba Siddique is a Director at Ranfa Pharmaceuticals Private Limited (since 2022). The company operates in Healthcare. Ranfa Pharmaceuticals Private Limited reported revenue of ₹17.6 Lakh (FY 2025).

DIN 09488466
Primary Designation Director
Industry Healthcare
First Appointment 01 Feb 2022
Oldest Company Age 4 yrs
Largest company Ranfa Pharmaceuticals Private Limited · ₹17.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Feb 20222022₹17.6 Lakh (FY 2025)Active

Board colleagues of Ariba Siddique

Directorship timeline

Open interactive timeline →
Ranfa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ariba Siddique

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ariba Siddique

Ariba Siddique currently holds 1 directorship: Ranfa Pharmaceuticals Private Limited (Director, since 01 Feb 2022, revenue ₹17.6 Lakh (FY 2025)).

Ariba Siddique was first appointed on 01 Feb 2022 as Director at Ranfa Pharmaceuticals Private Limited.

The current boards of Ariba Siddique's companies include Mohd Nazrul Islam (Ranfa Pharmaceuticals Private Limited), Rubeda Hamid (Ranfa Pharmaceuticals Private Limited), Runi Khatun (Ranfa Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available